Stay updated on Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Sign up to get notified when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.

Latest updates to the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page
- Check2 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on lifitegrast ophthalmic solution for dry eye disease, including detailed study criteria and descriptions. Additionally, a new version number has been added.SummaryDifference20%
- Check9 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check53 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check67 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check74 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check89 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.